• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION SYNVISC ONE; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION SYNVISC ONE; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Patient Problems Extreme Exhaustion (1843); Headache (1880); Hyperthermia (1909); Nausea (1970); Pain (1994); Swelling/ Edema (4577)
Event Date 08/29/2023
Event Type  Injury  
Event Description
I received a gel shot called synvisc one in my right knee on (b)(6) 2023.In 48 hours my knee swelled tremendously and had unbearable pain.On (b)(6) 2023 my dr removed 90 cc of fluid from my knee and said i'm having a severe reaction.The fluid was sent to the lab and no infection was found.On (b)(6) 2023 i received another aspiration of 55 cc of fluid.It is now 30 days after the injection and my knee is still swollen, hot, painful, i'm nauseous, have headaches, exhausted, my dr will not remove any more fluid at this time because my knee is so agitated.He is not sure how long these side effects will take to get out of my system.He has scheduled an mri to see if i have any tissue damage.This product contains formaldehyde, not sure if that's what my body is fighting.30 days later, can't walk much, and still so sick.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC ONE
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
GENZYME CORPORATION
MDR Report Key17863110
MDR Text Key324890057
Report NumberMW5146469
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 09/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/02/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Patient Sequence Number1
Treatment
MULTIVITAMIN ; OMEPRAZOLE 20MG
Patient Outcome(s) Other;
Patient Age65 YR
Patient SexFemale
Patient Weight108 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-